Skip to content
  • Saturday, 15 August 2026
  • 1:23 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Identification of CD99L2 Gene Variants as a Novel Driver of X-linked Spastic Ataxia Unlocks New Pathways in Neurodegenerative Research
Neuroscience & Brain Research

Identification of CD99L2 Gene Variants as a Novel Driver of X-linked Spastic Ataxia Unlocks New Pathways in Neurodegenerative Research

Rifan Muazin Jun 23, 2026 0

In a significant breakthrough for the field of clinical genetics and neurology, a collaborative team of researchers in Germany has…

Read More
Neuroscience & Brain Research

German Researchers Identify CD99L2 Gene as Key Driver of X-linked Spastic Ataxia

Rifan Muazin Jun 14, 2026 0

In a major advancement for the field of neurogenetics, a collaborative team of scientists in Germany has identified a previously…

Read More
BD and Wellstar Connect Pharmacy-to-Bedside Medication Management with AITWiV 1293: The enemy of your parasite is your friendAI Transforms Pharmaceutical Regulatory Submissions: Predictive Intelligence and End-to-End Pipelines Emerge as Game-ChangersTop pharma companies set sustainability goals, but emissions are still increasing
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ